Cities for Better Health Childhood Obesity Prevention Initiative
← catalyst calendarNCT06855563 · readout in 499 d
Sponsored by Novo Nordisk A/S (industry) · NVO — their whole pipeline →.
Phase
Not applicable
Status
Enrolling by invitation
Study type
Interventional
Design
Non randomized · None · Prevention
Enrollment
36,000estimated
Sites
6
Countries
Australia, Brazil, Canada +3
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2025-04-30 | actual | When the study began enrolling |
| Primary completion | 2027-12-31 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2027-12-31 | estimated | The whole study's end, after follow-up |
| First posted | 2025-03-04 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-12-19 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Obesity
Intervention
- Behavioral: Community-based intervention packages
Primary outcome
what the primary-completion date above is the date OFBody mass index z-score (BMI-z) adjusted for age and sex
measured At baseline, 1st follow-up (10-12 months) and 2nd follow-up (20-24 months)
Permalink · NVO's whole pipeline · Catalyst calendar · Every registered study · What changed